US 12,109,218 B2
Compositions of grapiprant and methods for using the same
Lesley Rausch-Derra, Parkville, MO (US); Tamara Newbold, Martinsville, NJ (US); Gopinath Devaraj, Auckland (NZ); and Akemi Shiraishi, Auckland (NZ)
Assigned to ARATANA THERAPEUTICS, INC., Leawood, KS (US)
Filed by ARATANA THERAPEUTICS, INC., Leawood, KS (US)
Filed on Dec. 13, 2021, as Appl. No. 17/548,755.
Application 15/144,609 is a division of application No. 14/639,898, filed on Mar. 5, 2015, granted, now 11,369,621.
Application 17/548,755 is a continuation of application No. 15/144,609, filed on May 2, 2016, abandoned.
Claims priority of provisional application 62/089,713, filed on Dec. 9, 2014.
Prior Publication US 2022/0096501 A1, Mar. 31, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/64 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 31/437 (2006.01)
CPC A61K 31/64 (2013.01) [A61K 9/0053 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 31/437 (2013.01)] 14 Claims
 
1. A method for treating pain and inflammation in a cat or a dog, the method comprising administering to the cat or the dog an oral pharmaceutical composition comprising a therapeutically effective amount of grapiprant and one or more excipients;
wherein the therapeutically effective amount of grapiprant is administered at a dosage rate of 2 mg per kilogram bodyweight of the cat or the dog once per day; and
wherein the oral pharmaceutical composition is administered with or without food.